HMMR and breast carcinoma: That is, the N-terminal domain of HMMR binds microtubules, encoded in part by exon 4 [16,19], and the expression of a naturally occurring splice variant that lacks exon 4 (-exon 4) correlates with progression of multiple myeloma [73] and breast cancers [78].